Dawaa Reference

chronic

Benign Eye Tumor

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class FD25.00 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against3 documents
  • No dose - referral pathway, no medicine given in primary care
  • Benign and Malignant Iris Tumors - disease-level clinical article (benign-eye-tumor-clinical.txt)
  • Benign and Malignant Iris Tumors - disease-level clinical article (benign-eye-tumor-full.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (2)

  • Patients often notice a discolored spot or patch on the iris themselves
  • Blurred vision and pain can occur but are not typical [blurred vision · eye pain]

Signs — what you find (7)

  • A pigment-epithelium iris cyst is one-sided, darker in color, and lets light pass through it [cyst]
  • A stromal iris cyst tends to appear in the first decade of life with a smooth, see-through front surface [cyst]
  • An iris nevus is usually smaller than a melanoma, under 3 mm across and 1 mm thick
  • Iris pigment epithelium adenoma shows up as a dark grey lesion near the outer edge of the iris, sometimes with several nodules
  • Iris leiomyoma is typically a single, slow-growing, well-defined nodule that is lightly or not pigmented
  • Yellow nodules on the iris with bleeding into the eye and skin lesions point to juvenile xanthogranuloma [bleeding · skin lesions]
  • Vascular growths on the iris often show up with sudden bleeding into the eye and resulting blurry vision [bleeding]

Tests (6)

  • Checking eye pressure and the drainage angle is recommended given the risk of glaucoma with these growths
  • Ultrasound biomicroscopy helps size the lesion and tell a solid mass apart from a fluid-filled one
  • Fine-needle sampling can settle the diagnosis when imaging alone is not conclusive
  • Immunohistochemistry and electron microscopy are needed to confirm a leiomyoma, since it often mimics other growths
  • Chest imaging is advised when sarcoidosis is suspected as the cause of iris nodules
  • Fluorescein angiography is key to working up a vascular growth on the iris

If not this — what else fits (9)

  • Inflammatory granuloma
  • Epithelial ingrowth
  • Congenital iris heterochromia
  • Fuchs heterochromic iridocyclitis
  • Iris nevus syndrome
  • Pigment dispersion syndrome
  • Hemosiderosis
  • Pigmentary glaucoma
  • Ocular siderosis

SourceStatPearls "Benign and Malignant Iris Tumors" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A non-cancerous growth of the eye or its surrounding structures; a GP refers to ophthalmology for assessment and possible removal rather than treating it. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A non-cancerous growth of the eye or its surrounding structures; a GP refers to ophthalmology for assessment and possible removal rather than treating it.

Cautions
  • RED FLAG - Visual field defects, proptosis, or increased intraocular pressure: assess urgently and refer.
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Patients should seek immediate medical attention for changes in vision, acute eye pain, or visible changes in the tumor due to secondary glaucoma risk.
  • RED FLAG - Irregularly contoured lesions thicker than 0.5-1.0 mm, increased vasculature, spontaneous hyphema, or pupillary peeking indicate potential malignancy.
  • RED FLAG - A change in the size or colour of the lesion, or bleeding from it: re-evaluate for malignant transformation.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.